Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaike Chemical Group Regulatory News (HAIK)

  • There is currently no data for HAIK

Half Yearly Report

24 Sep 2009 07:00

RNS Number : 5658Z
HaiKe Chemical Group Ltd.
24 September 2009
Β 

ο»Ώ

24Β September 2009

HaiKe Chemical Group Ltd.

INTERIMΒ RESULTS FOR THE SIX MONTHS ENDEDΒ 

30 JUNE 2009Β (UNAUDITED)

HaiKe Chemical Group Ltd. ("HaiKe" or the "Company"), the AIM quoted (AIM: HAIK) petrochemical, speciality chemical and biochemical business based in China, is pleased to announce its unaudited results for the six months ended 30 June 2009.

Highlights

Total revenues decreasedΒ byΒ 17.6% to US$("$") 261.5mΒ over the same period last yearΒ (H1Β 2008: $317.5m)
Petrochemical revenues decreasedΒ byΒ 18.2% to $218.2m (H1Β 2008: $266.8m), although sales volumes increased by 8%
Speciality chemical and biochemical revenues decreasedΒ byΒ 14.4% to $43.4m (H1Β 2008: $50.7m), although volumes increased by 68%
Gross margin increased toΒ 8.8% (H1Β 2008: 3.6%)
Profit after taxΒ wasΒ $10.8m (H1Β 2008: loss of $1.0m)
Profit after minority interestsΒ wasΒ $10.0m (H1Β 2008: loss of $3.0m)
Construction of theΒ Ruilin joint ventureΒ refinery is progressingΒ on scheduleΒ 

Mr. Yang Xiaohong, Executive Chairman, said:

"I am pleased to present our results for the firstΒ six monthsΒ of 2009, during which time the Company returned to profitability, following a loss reported in the same periodΒ inΒ 2008. This was largely due to increased profit margins in the oil refinery business.Β InΒ earlyΒ 2009, the PRCΒ Government implemented a new pricing mechanism for refined products and made five successive adjustments to the prices of domestic refined products in order to align the price trends of domestic refined products to international crude oil prices.Β As a result, the Company's petrochemicalΒ divisionΒ recorded an impressive $12.4m profitΒ in the first six months of 2009. ThisΒ comparesΒ withΒ  aΒ loss of $6.2mΒ in the first half ofΒ last year.

With the background ofΒ theΒ global financial crisis, thereΒ has beenΒ a slowdown in the real economy andΒ aΒ decline in demand for chemical products.Β InΒ response, the PRC government successfully launched a RMB4 trillion stimulus plan and implemented a series of policiesΒ aimed at recovery. These includedΒ substantially raising tax refunds on the export of chemical products and their related finished products. I believeΒ this will have aΒ positive impact onΒ overall economic activity, whichΒ in turnΒ will improve theΒ prospects for theΒ Company's speciality chemicalΒ division.Β 

While we recognise the volatileΒ nature ofΒ most of the markets we operate in, the Company willΒ continue toΒ focus on the market development of our speciality chemical products andΒ onΒ improvingΒ the flexibility of our petrochemical business model."

For further information please contact:

HaiKe

Nick Su,Β Chief Finance Officer

+86 (0) 546 8289175

Hanson Westhouse

Tim MetcalfeΒ /Β Martin DavisonΒ / Christine Zhang

+44 (0) 20 7601 6100

Cardew Group

Rupert PittmanΒ /Β Shan Shan WillenbrockΒ /Β Catherine MaitlandΒ 

+44 (0) 20 7930 0777

First Half 2009 Results

Operating profit increasedΒ significantly byΒ 185% from $5.5m inΒ the first half ofΒ 2008 to $15.7m in 2009, and profit after tax was $10.8m (H1Β 2008: loss after tax of $1.0m). The gross margin improvedΒ significantlyΒ from 3.6% in 2008 toΒ 8.8% in 2009.The improvement in the Company's profitability was largely due to the relatively stable oil prices experienced in the first half of 2009.Β 

Total revenue decreasedΒ byΒ 17.6% from $317.5m in 2008 to $261.5m in 2009. On aΒ divisionalΒ Β basis,Β revenue fromΒ petrochemical products decreased from $266.8m in 2008 to $218.2m in 2009 asΒ aΒ result of an averageΒ 28%Β  decreaseΒ inΒ sellingΒ price,Β althoughΒ salesΒ volume increasedΒ byΒ 8%.Β Revenue fromΒ specialityΒ chemical products decreasedΒ byΒ 14.4% from $50.7m in 2008 to $43.4m in 2009 asΒ aΒ result of an averageΒ 31%Β decreaseΒ inΒ sellingΒ  price.Β Trading volumeΒ increasedΒ byΒ 68%.

Cost of sales decreasedΒ byΒ 22.1% from $306.2m in 2008 to $238.4m in 2009, reflecting decreasingΒ raw materialΒ  pricesΒ and the Company's effective control on costs.Β The overall refineryΒ utilisation rateΒ was atΒ 72%,Β giving aΒ yieldΒ of approximatelyΒ 98%. This helpedΒ to decrease the cost ofΒ final product production.Β In theΒ specialityΒ chemicalΒ  division,Β the Company hasΒ undertakenΒ a series ofΒ strictΒ cost controlΒ measurements to minimiseΒ itsΒ electricity consumption andΒ to improveΒ raw material yield.Β 

Sales and distribution expenses were marginallyΒ reducedΒ from $2.2m in 2008 to $2.1m in 2009. Other administrative expenses increased slightly from $4.5m in 2008 to $5.3m in 2009, asΒ aΒ result ofΒ increasedΒ salary and employee benefitΒ costs. Finance costs decreased from $5.6m in 2008 to $4.6m in 2009 due toΒ aΒ decreaseΒ inΒ the primeΒ interestΒ rate inΒ ChinaΒ from 6.57% to 5.58% during the period.

The income tax expenses decreased from $0.7m in 2008 to $0.1m in 2009 dueΒ to theΒ carried forward taxable loss recorded in 2008. The carried forward loss will be availableΒ toΒ offset against future taxable profit ofΒ HaiKe's subsidiaries companies.

The profit attributable to the shareholders of HaiKe inΒ the first half ofΒ 2009 wasΒ $10.0mΒ comparedΒ with a loss of $3.0m in 2008.

Basic and dilutedΒ earningsΒ per share were both US 26 cents in 2009, compared with a loss per share of US 7.8 cents in 2008.

Capital expenditure

Investment in property, plant and equipment increased from $25.5m inΒ the first half ofΒ 2008 to $51.5m inΒ the same period inΒ 2009, mainly due toΒ theΒ construction workΒ for variousΒ expansionΒ projects. These projects are: 1)Β theΒ  construction of RuilinΒ refineryΒ facilitiesΒ which will be completed in the first half of 2010;Β andΒ 2)Β theΒ construction ofΒ a new production and a research and development facilityΒ forΒ Tiandong BiochemicalΒ which will be finished in theΒ secondΒ half of 2009.Β 

To continueΒ toΒ meetΒ theΒ increasingΒ environmentalΒ requirements, HaiKe'sΒ refineryΒ divisionΒ is building a sulphur collection system and a hydrogenisation systemΒ to achieveΒ aΒ cleanerΒ gasoline output. ConstructionΒ costs for the two facilitiesΒ in 2009Β wereΒ $9.7m;Β theyΒ are expected to be commissioned in theΒ fourthΒ quarter of 2009.Β 

Cash flows

InΒ the first half ofΒ 2009, cash used for operating activities amountedΒ toΒ $25.7mΒ comparingΒ toΒ $2.5m in 2008 due toΒ increasedΒ refinery feedstock inventory.

Cash outflow for investment in property, plant and equipmentΒ of $41.5m was mainly funded fromΒ anΒ increase in bankΒ  facilities, from $156.4m as at 31 December 2008 to $208.1m as at 30 June 2009, in which long term project financingΒ increased from $2.9m in 2008 to $17m. Within theΒ ChineseΒ banking system, it is common to provide bank borrowings on a short term renewal basis to most non-government controlled enterprises. It is expected that allΒ HaiKe'sΒ short term facilities will be renewed when they fall due.

Cash and cash equivalentsΒ marginally increased from $34.7m as at 31 December 2008 to $37.1mΒ as at 30 June 2009.

Liquidity and financial risk

We believe that the Company has sufficient funds to meet foreseeable business requirements due to a number ofΒ factors. TheseΒ includeΒ raw material costs,Β whichΒ are currently stableΒ and marginally decreasing, resulting in an anticipated improvement in overall market demand in bothΒ theΒ petrochemical and speciality chemical sectors.

Operational Review

During the first half of 2009, the petrochemicalΒ divisionΒ continued to experience slowingΒ market conditionsΒ inΒ the industrial sector, especiallyΒ as theΒ salesΒ priceΒ ofΒ dieselΒ droppedΒ byΒ 28% andΒ salesΒ volume droppedΒ byΒ 12%Β  comparedΒ toΒ the same period last year. Sales volume of gasoline increasedΒ byΒ 59%,Β asΒ aΒ result ofΒ the growing numberΒ ofΒ family vehicles,Β althoughΒ the sales price dropped by 18%Β compared to the first half of 2008.Β This has contributed to the overall decrease in the group revenue in the period. However, we believe with the PRC government'sΒ stimulus plan,Β the overall market demandΒ forΒ diesel will recoverΒ inΒ the second half of 2009.Β 

The Company believes that the pricing mechanism of refined products implemented in MayΒ this yearΒ will help the Company to respond toΒ the movement of global crude and fuel oil marketsΒ more quickly. UnderΒ theΒ current pricing mechanismΒ and the relatively stable crude oil price, the Company hasΒ better visibility forΒ the selling prices of refined products, which provides the Company withΒ betterΒ flexibilityΒ and forward planningΒ to sourceΒ feedstock into the refinery facilities.

In the specialityΒ chemicalΒ division, as a result of the ongoing challenging market conditions,Β aΒ difficult periodΒ was experiencedΒ in the first six months of 2009.Β The priceΒ forΒ DMC,Β our major speciality chemical product, droppedΒ byΒ 32%,Β with the salesΒ volumeΒ droppingΒ byΒ 42% due toΒ aΒ slowdown inΒ the overseas demand for this product.Β Raw material prices for DMC decreased during the first half of 2009,Β butΒ the reduction in theΒ production costsΒ was unable to offset the fall in revenue. This resulted in the division contributing negatively to the group in terms of profit.Β However, we believe that the situationΒ will be reversed in theΒ secondΒ half of 2009 withΒ generalΒ global economic recovery andΒ with the benefit of theΒ local economic stimulus planΒ forΒ mid industrials.Β In the first half of 2009,Β demand forΒ the chloral-alkali business increasedΒ fromΒ theΒ domesticΒ basic industriesΒ such asΒ cement, glass and automobile manufacturing.

The biochemical business, being part of the speciality chemicalΒ division, remains the Company's smallest contributor to group revenue, although revenue increased by 307%Β toΒ $6.9mΒ with gross profit growingΒ by 256% compared to 2008. BothΒ theΒ selling price andΒ the price ofΒ heparinΒ raw materialsΒ increasedΒ comparedΒ to the same periodΒ last year.Β Most ofΒ theΒ demandΒ wasΒ fromΒ new marketsΒ such as South America andΒ Russia.Β In addition,Β the biochemicalΒ businessΒ successfully passed the quality assurance auditΒ fromΒ BrazilΒ in 2009. This will help the Company access theΒ strongΒ growth of theΒ Brazilian market.Β ByΒ the end ofΒ June 2009, the biochemicalΒ businessΒ has already obtained quality assurance certificatesΒ inΒ Brazil,Β theΒ European Union, andΒ India.

Outlook

Since the beginning of 2009 we have seen the petrochemical marketΒ bothΒ recoverΒ and stabilise. The crude oil priceΒ has seen less volatilityΒ andΒ theΒ PRC governmentΒ has beenΒ more activeΒ inΒ response to crude oilΒ price fluctuations.Β However, theΒ Chinese petrochemical marketΒ itself remains volatile and small changes in the market dynamics can have a material effect on the Company's profitability.Β This was particularly apparent inΒ July andΒ August when losses were made on the Company's refining activities, due toΒ a relatively high priced fuel oil feedstock inventory, coupled with relatively low yields of gasoline and diesel. This situationΒ has improved since the PRC government mandated price rise for refined products earlier this monthΒ and the outlook for the remainder of the year is more positive.

TheΒ CompanyΒ continuesΒ toΒ maintainΒ good relationships with Sinopec, PetroChinaΒ andΒ CNOOC, in particular,Β as thisΒ canΒ benefit the CompanyΒ in terms ofΒ furtherΒ stabilisingΒ itsΒ oil supplies.Β In addition,Β the Company has already started toΒ look at various options including hedgingΒ in orderΒ to protectΒ the Company fromΒ oil price volatility.Β 

The speciality chemicalΒ divisionΒ had a difficult period in the first half of 2009, impacted by theΒ global economic crisis. The focus for the second half of 2009 is to continueΒ toΒ marketΒ theΒ specialtyΒ chemical productsΒ domestically.Β This, alongΒ withΒ theΒ government'sΒ stimulus plan andΒ theΒ gradual recoveryΒ inΒ theΒ global economy,Β should seeΒ trading conditions for theΒ speciality business improve.

In the biochemical business, the CompanyΒ is looking toΒ complete the construction ofΒ theΒ newΒ facilitiesΒ later this year.Β TheΒ additional production facilities, coupled with the new research and development capabilityΒ willΒ assist with the development of the biochemical business and will ensure that it continues its significant growth.

Β 

Consolidated statement of comprehensive incomeΒ 

For the 6 months ended 30 June 2009

Notes

6 months ended 30 June 2009

6 months ended 30 June 2008

Year

Β ended 31 December 2008

(Unaudited)

(Unaudited)

(Audited)

$000

$000

$000

RevenueΒ 

261,527Β 

317,524

631,533

Cost of salesΒ 

(238,444)

(306,230)

(633,494)

Gross profit/(loss)

23,083Β 

11,294

(1,961)

Other incomeΒ 

303Β 

924

868

Distribution costsΒ 

(2,146)

(2,195)

(3,510)

Administrative expensesΒ 

(5,305)

(4,527)

(11,770)

Other expensesΒ 

(192)

-

-

Profit/(loss) from operations

15,743

5,496

(16,373)

Finance costsΒ 

(5,371)

(5,983)

(15,349)

Finance incomeΒ 

753

406

2,104

Share of results of associatesΒ 

(154)

(135)

(77)

Profit/(loss)Β before tax

10,971Β 

(216)

(29,695)

Income tax expenseΒ 

3

(142)

(736)

(992)

Profit/(loss)Β for the periods/year from continuing operations

10,829Β 

(952)

(30,687)

Other comprehensive income:Β 

Exchange differences on translating foreign operationsΒ 

19

3,624

3,361

Total comprehensive income for the periods/yearΒ 

10,848

2,672

(27,326)

Profit/(loss)Β attributable to:Β 

Owners of the parentΒ 

9,903Β 

(2,975)

(29,234)

Minority interestΒ 

926Β 

2,023

(1,453)

10,829

(952)

(30,687)

Total comprehensive incomeΒ 

attributable to:Β 

Owners of the parent

9,922

230

(25,873)

Minority interestΒ 

926

2,442

(1,453)

10,848

2,672

(27,326)

Earnings per share for profit/(loss) attributableΒ to the equity holders of the parent during theΒ periods/year

γ€€

γ€€

Β -BasicΒ 

4

0.258

(0.078)

(0.762)

Β -Diluted

4

0.258

(0.078)

(0.762)

Β Β Consolidated balance sheet

As at 30 June 2009Β 

Notes

30 Jun

30 Jun

31 December

2009

2008

2008

(Unaudited)

(Unaudited)

(Audited)

$000

$000

$000

AssetsΒ 

Non-current assetsΒ 

Property, plant and equipmentΒ 

187,410

131,090

145,545

Investments in equity-accounted associatesΒ 

-

187

204

Available-for-sale investmentΒ 

143

544

544

Intangible assetsΒ 

8,645

4,455

5,082

Deferred tax assetsΒ 

3

756

734

791

γ€€

196,954

137,010

152,166

Current assetsΒ 

InventoriesΒ 

71,648

67,941

38,887

Trade and other receivablesΒ 

16,254

33,183

25,240

Income tax receivable

3,732

-

-

Amounts due from related partiesΒ 

-

-

299

Restricted cashΒ 

67,737

-

56,313

Cash and cash equivalentsΒ 

37,052

42,943

34,728

γ€€

196,423

144,067

155,467

Total assetsΒ 

393,377

281,077

307,633

LiabilitiesΒ 

Non-current liabilitiesΒ 

Long-term loanΒ 

16,834

2,916

2,926

Deferred income

1,446

1,264

1,739

18,280

4,180

4,665

Current liabilitiesΒ 

Short-termΒ loanΒ 

191,258

144,529

153,475

Trade and other payablesΒ 

79,815

63,808

74,991

Amounts due to related partiesΒ 

34,532

7,532

43,637

Deferred incomeΒ 

202

146

202

Income tax payableΒ 

-

2,124

1,385

305,807

218,139

273,690

Total liabilitiesΒ 

324,087

222,319

278,355

γ€€

Equity

Share capitalΒ 

77

77

77

Share premiumΒ 

18,338

18,338

18,338

Other reservesΒ 

6,145

4,510

6,145

Statutory reservesΒ 

2,722

3,996

2,722

Retained earnings/(accumulated losses)

(3,931)

13,221

(13,834)

Foreign currency translation reserveΒ 

6,291

6,116

6,272

Total equity attributable to equity holders of the parentΒ 

29,642

46,258

19,720

γ€€

Minority interestsΒ 

39,648

12,500

9,558

Total equity and liabilitiesΒ 

393,377

281,077

307,633

Β Β 

Consolidated statement of changes in equityΒ 

For the six months ended 30 June 2009

Attributable to equity holders

For the six months ended 30 June 2009 (Unaudited)

Share

capital

Share

premium

Other

Reserves

Statutory

Β reserves

Accumulated

losses

Foreign currency

translation reserve

Total

γ€€

Minority interests

Total

γ€€

$000

$000

$000

$000

$000

$000

$000

$000

$000

Balance as at 1 January 2009

77

18,338

6,145

2,722

(13,834)

6,272

19,720

9,558

29,278

CapitalΒ injectionΒ by minority shareholders

-

-

-

-

-

-

-

29,851

29,851

Total comprehensive income for the period

-

-

-

-

9,903

19

9,922

926

10,848

Dividend paid

-

-

-

-

-

-

-

(687)

(687)

Balance as at 30 June 2009

77

18,338

6,145

2,722

(3,931)

6,291

29,642

39,648

69,290

Attributable to equity holders

For the six months ended 30 June 2008Β (Unaudited)

Share

capital

Share

premium

Other

Reserves

Statutory

reserves

Retained

earnings

Foreign

currency

translation reserve

Total

Minority interests

Total

$000

$000

$000

$000

$000

$000

$000

$000

$000

Balance as at 1 January 2008Β 

77

18,338

4,510

3,996

16,196

2,911

46,028

10,058

56,086

Total comprehensiveΒ lossΒ for the period

-

-

-

-

(2,975)

3,205

230

2,442

2,672

Balance as at 30 June 2008

77

18,338

4,510

3,996

13,221

6,116

46,258

12,500

58,758

Attributable to equity holders

For the year ended 31 December 2008 (Audited)

Share

capital

Share

premium

Other

reserves

Statutory

reserves

Retained

earningsΒ /(accumulated)

losses

Foreign

currency

translation reserve

Total

Minority interests

Total

γ€€

γ€€

$000

$000

$000

$000

$000

$000

$000

$000

$000

Balance as at 1 January 2008

77

18,338

4,510

3,996

16,196

2,911

46,028

10,058

56,086

Capital injection to subsidiary from minority shareholders

518

-

518

-

518

Total comprehensiveΒ lossΒ for the year

-

-

-

-

(29,234)

3,361

(25,873)

(1,453)

(27,326)

TransferΒ from/(to)Β statutory reserve

-

-

1,635

(1,195)

(440)

-

-

-Β 

-

Transfer to minority interest

-

-

-

(79)

(874)

-

(953)

953

-

Balance as at 31 December 2008

77

18,338

6,145

2,722

(13,834)

6,272

19,720

9,558

29,278

Β Β 

Consolidated cash flow statementΒ 

For theΒ six monthsΒ ended 30 June 2009

6 months ended 30 June 2009

6 months ended 30 June 2008

Year ended 31 December 2008

(Unaudited)

(Unaudited)

(Audited)

γ€€

$000

$000

$000

Profit/(loss)Β before tax from continuing operations

10,971

(216)

(29,695)

Adjustments for:Β 

γ€€

Amortization of intangible assets

34

84

153

Depreciation of property, plant and equipmentΒ 

6,531

5,594

15,422

LossΒ on disposal of property, plant and equipmentΒ 

117

6

227

Amortisation of deferred capital grantsΒ 

(95)

(71)

(195)

Impairment loss on loans and receivablesΒ 

-

117

(231)

Gain on disposal of available-for-sale financial assets

(570)

-

-

Share of results of associatesΒ 

-

135

77

Dividend income from investment securitiesΒ 

-

(71)

(62)

Gain on disposal of investment securitiesΒ 

-

-

(20)

Foreign exchange gainsΒ 

-

-

(1,237)

InterestΒ incomeΒ 

(753)

(406)

(804)

Financial expenseΒ 

5,371

5,983

15,349

Cash flow from operating activities before changesΒ 

of working capital and provisionsΒ 

21,606

11,155

(1,016)

Working capital changes:Β 

(Increase)/decrease in:Β 

InventoriesΒ 

(40,012)

(19,706)

8,909

Trade and other receivablesΒ 

8,995

(1,390)

531

Amounts due from related partiesΒ 

299

-

(294)

Restricted cashΒ 

(11,392)

-

(35,701)

Increase/(decrease) in:Β 

Trade and other payablesΒ 

(2,648)

7,693

13,960

Amounts due to related parties

-

(157)

-

Cash used inΒ operations

(23,152)

(2,405)

(13,611)

Interest receivedΒ 

753

406

804

Income tax paidΒ 

(3,275)

(496)

(1,629)

Net cash flows from operating activities

(25,674)

(2,495)

(14,436)Β 

γ€€

Cash flows from investing activitiesΒ 

Purchase of property, plant and equipmentΒ 

(41,541)

(28,579)

(39,775)

Purchase ofΒ intangible assetsΒ 

(5,502)

(1,153)

(1,894)

Government grant receivedΒ 

-

-

425

PurchaseΒ of available-for-saleΒ financial assetsΒ 

-

-

(13)

SaleΒ of financial assets held for tradingΒ 

-

285

308

Dividend income fromΒ available-for-saleΒ financial assetsΒ 

-

71

62

Sales of available-for-sale financial assetsΒ 

544

-

-

Gain on sales of available-for-sale financial assetsΒ 

570

-

-

Proceeds from disposal of property, plant and equipmentΒ 

-

27

115

Cash flows used in investing activitiesΒ 

(45,929)

(29,349)

(40,772)

Cash flows from financing activitiesΒ 

Capital injection from minority shareholders in subsidiariesΒ 

29,850

-

518

Increase inΒ borrowingsΒ 

108,110

116,858

270,524

Decrease inΒ borrowingsΒ 

(48,867)

(62,376)

(207,184)

Loans from related partiesΒ 

(9,123)

-

35,333

Interest paidΒ 

(5,371)

(5,983)

(15,349)

Dividends paidΒ to minoritiesΒ 

(687)

-

-

Cash flows from financing activitiesΒ 

73,912

48,499

83,842

NetΒ increase in cash and cash equivalents

2,309

16,655

28,634

Cash and cash equivalents at beginning of periods/yearΒ 

34,728

24,319

5,585

Foreign exchangeΒ translationΒ differencesΒ 

15

1,969

509

Cash and cash equivalents at end of periods/yearΒ 

37,052

42,943

34,728

Β Β 

Notes to the interim consolidated financial informationΒ 

For the six months ended 30 June 2009Β 

1. General informationΒ 

Haike ChemicalΒ Group Ltd. (theΒ "Company") was incorporated on 20 June 2006. The address of the registered office is atΒ ScotiaΒ CenterΒ 4thΒ Floor,Β P.O. Box 2804Β George Town, Grand Cayman,Β Cayman Islands. The principal activity of the Company is that of investment holding. The Company's ultimate parent company is Hi-Tech Chemical Investment Limited, a company incorporated in theΒ British Virgin Islands.

The principal activities of the Group are manufacturing of petrochemical and chemical products. The principal place of business of the CompanyΒ is West of Boxin Road, Shikou Country,Β Dongying City,Β ShandongΒ Province,Β China.

The financial statements present information about the Company and its subsidiaries as a consolidated group of companies.

2. Accounting policies

Basis of presentation

Β 

The financial information has been prepared using the recognition and measurement principles of International Accounting Standards, International Financial Reporting Standards and interpretations adopted for the use in the European Union. The principle Accounting Policies used in preparing the interim statements are those the group expects to apply in its financial statements for the year ended 31 December 2009 and are unchanged from those disclosed in the group's report and financial statements for the year ended 31 December 2008, except that the requirements of IAS 1(revised), Presentation of Financial Statements, have been adopted, resulting in the presentation of a consolidated statement of changes in owners' equity. This presentation has been applied to comparative information in this report. Financial information for the six months ended 30 June 2009 and for the six months ended 30 June 2008 is unaudited and does not constitute the group's financial statements for those periods. Comparative financial information for the full year ended 31 December 2008 has, however, been derived from the audited financial statements for that period. The Board of Directors approved this interim statement onΒ 24 SeptemberΒ 2009.

Β 

3. BusinessΒ divisionsΒ 

The following tables present certain sales, profit regarding the Group's businessΒ divisionsΒ for the periodsΒ ended 30 June 2008 and 2009.Β 

Six months to

30 June 2009 (Unaudited)

6 months ended 30 June 2009

6 months ended 30 June 2008

Year ended 31 December 2008

(Unaudited)

(Unaudited)

(Audited)

$000

$000

$000

Sales to external customers

Petrochemical

218,177

266,840

526,939

Chemical products

43,350

50,684

104,594

261,527

317,524

631,533

Profit/(loss) for theΒ periods/year

Petrochemical

12,602

(6,235)

(36,761)

Share of associate

(154)

-

(77)

12,448

(6,235)

(36,838)

Chemical products

(706)

6,618

8,254

Unallocated expenses

(771)

(599)

(1,111)

Profit/(loss) from operation before tax

10,971

(216)

(29,695)

Income taxΒ expense

(142)

(736)

(992)

Profit/(loss) for theΒ periods/year

10,829

(952)

(30,687)

Β Β  BusinessΒ divisions(Cont'dοΌ‰

Six months to

30 June 2009 (Unaudited)

30Β June

Β 2009

30Β June

2008

31Β December 2008

(Unaudited)

(Unaudited)

(Audited)

$000

$000

$000

Divisional assets

Petrochemical

248,386

222,772

247,981

Investment in associates

-

187

61

248,386

222,959

248,042

Chemical products

243,625

107,798

113,781

Unallocated assets

436

706

239

Less: Intersegment balance

(99,070)

(50,386)

(54,429)

393,377

281,077

307,633

DivisionalΒ liabilities

Petrochemical

267,807

182,271

242,040

Chemical products

157,991

86,606

86,904

UnallocatedΒ liabilities

3,842

3,828

3,840

Less: Intersegment balance

(105,553)

(50,386)

(54,429)

324,087

222,319

278,355

OtherΒ divisionΒ information

Capital expenditures

Petrochemical

41,069

3,687

17,821

Chemical products

10,428

21,807

32,449

51,497

25,494

50,270

Depreciation and amortisation

Petrochemical

3,187

3,223

9,568

Chemical products

3,378

2,455

6,007

6,565

5,678

15,575

Β GeographicalΒ divisionsΒ 

Β Six months to 30 June 2009 (Unaudited)

Six months to 30 June 2009

Domestic sales

Export sales

Total

Segment sales

2009

2008

2009

2008

2009

2008

$000

$000

$000

$000

$000

$000

251,450

310,653

10,077

6,871

261,527

317,524

Β TwelveΒ months to 31 Dec 2008 (Audited)Β 

Β 

Twelve months to
31 December 2008
Β 
Domestic sales
2008
$000
Β 
Export sales
2008
$000
Β 
Total
2008
$000
Β 
Β 
Β 
Β 
Segment sales
Β 
614,427
Β 
17,106
Β 
631,533

3. TaxationΒ 

γ€€

6 months ended 30Β June 2009

6 months endedΒ 30Β June 2008

Year endedΒ 

31Β December 2008

γ€€Six months to 30 June 2009 (Unaudited)

(Unaudited)

(Unaudited)

(Audited)

γ€€

$000

$000

$000

Income tax expense is as follows:Β 

Current income taxΒ 

108

765

1,075

Origination and reversal of temporary differencesΒ 

34

(29)

(83)

γ€€

142

736

992

Relationship between tax expense and accounting profitΒ 

ReconciliationΒ between tax expense and the accounting profit multiplied by the applicable corporate tax rate is as follows:

Six months to

30 June 2009 (Unaudited)

6 months ended 30 June 2009

6 months ended 30 June 2008

Year ended

Β 31 December 2008

(Unaudited)

(Unaudited)

(Audited)

$000

$000

$000

Accounting profit/(loss) before

Β income tax

10,971

(216)

(29,695)

Tax at respective companies' domestic income tax rate

3,137

(54)

(7,071)

Effect of partial tax exemption

333

(1,006)

(922)

Tax effect of expenses not deductibleΒ for taxation purposes

-

583

-

Non-deductible expenses

-

-

(274)

Unrecognised tax loss

(2,922)

1,266

8,397

Utilisation of previously unrecognisedΒ tax loss

(214)

(53)

828

Share of results of associate

(192)

-

34

Income tax expenseΒ recognizedΒ in income statement

142

736

992

Deferred tax assets

Deferred income tax assets relates to the following:

γ€€

30Β June

2009

30Β June

2008

31Β December 2008

γ€€

(Unaudited)

(Unaudited)

(Audited)

γ€€

$000

$000

$000

Provision for doubtful debts

617

704

635

Allowance for long-term investment

26

30

26

Depreciation

113

-

130

756

734

791

Β Β 

Unrecognised tax losses

As at 30 June 2009, the Group has tax losses of approximately $5.1mΒ (30 June 2008:Β $5,8m; 31 December 2008: $8.6m) that are available to offset against future taxableΒ profits of the companies in which the losses arose and for which no deferred tax asset isΒ recognised due to uncertainty of its recoverability. The use of these tax losses is subject toΒ the agreement of the tax authorities and compliance with certain provisions of the taxΒ legislation ofΒ China.Β 

4. Earnings per share from continuing operations

Earnings for the purpose of basic and diluted earnings per share are the net profit/(loss)Β for six months ended 30 June 2009 attributable to equity holders of the parent ofΒ $9,903,494Β (for six months ended 30 June 2008: $2,975,000 of loss,Β for the year ended 31 DecemberΒ 2008:Β $29,234,000 of loss)

The profit/(loss)Β from continuing operations for the financial period attributable to equity holders of the parent is as follows:Β 

γ€€

6 months ended

30 JuneΒ 2009

6 months ended

30 JuneΒ 2008

Year ended

Β 31Β December

2008

γ€€

(Unaudited)

(Unaudited)

(Audited)

γ€€

$000

$000

$000

Profit/(loss)Β from continuing operations attributable to equity holders of the parentΒ 

9,903

(2,975)

(29,234)

The weighted average number of ordinary shares used in the calculation of earnings per share from continuing operations has been derived as follows:Β 

γ€€

6 months endedΒ 

30Β June

6 months endedΒ 

30Β June

Year ended

Β 31Β December

2009

2008

2008

γ€€

(Unaudited)

(Unaudited)

(Audited)

γ€€

$000

$000

$000

Number of ordinary sharesΒ 

γ€€

γ€€

γ€€

Weighted average number of ordinary shares - basicΒ 

38,353,571

38,353,571

38,353,571

Dilutive effect of share options

-

160,622

-

Weighted average number of ordinary shares - dilutedΒ 

38,353,571

38,514,193

38,353,571

5. ContingenciesΒ 

As at 30 June 2009, as a warrantor, the Group has guaranteed the bank loans of third partiesΒ to an aggregate amount of $125.8mΒ (30 June 2008: $50.0m; 31 December 2008:$57.5m).Β It is unlikely that any significant liability will arise because the financial statements of the warrantees indicate that the debtors are able to pay their debts as they mature.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IR PUUCUBUPBGQW
Date   Source Headline
19th Mar 20182:38 pmRNSExit Facility and Cancellation
12th Mar 20188:07 amRNSResult of EGM
16th Feb 20187:00 amRNSProposed Cancellation, EGM and Exit Facility
16th Jan 201810:00 amRNSTrading Update
21st Sep 20173:16 pmRNSHolding(s) in Company
1st Sep 20177:00 amRNSHalf-year Report
26th Jun 20177:00 amRNSResult of AGM and Company Update
2nd Jun 20175:11 pmRNSAnnual Financial Report
1st Jun 20177:12 amRNSFinal Results
26th May 201710:43 amRNSBoard Appointment
23rd Jan 20178:00 amRNSTrading Statement
27th Sep 20167:36 amRNSHalf-year Report
6th Sep 20167:09 amRNSTrading Update - Correction
20th Jul 20167:00 amRNSDirectorate Change
27th Jun 201611:38 amRNSResult of AGM
3rd Jun 201611:59 amRNSAnnual Financial Report
31st May 20167:00 amRNSFinal Results
11th May 20169:01 amRNSNotice of Results and Update
8th Jan 201610:38 amRNSTrading Statement
6th Jan 20167:00 amRNSChange of name of Nominated Adviser and Broker
25th Sep 20157:00 amRNSHalf Yearly Report
14th Sep 20157:00 amRNSTrading Statement
8th Jun 20157:00 amRNSResult of AGM
14th May 201512:38 pmRNSAnnual Financial Report and Notice of AGM
1st May 20157:00 amRNSFinal Results
23rd Jan 20157:00 amRNSTrading Statement
30th Sep 20148:02 amRNSHalf Yearly Report
21st Jul 20147:00 amRNSResult of AGM
30th Jun 201410:15 amRNSPosting of Annual Report and Accounts
25th Jun 20147:00 amRNSFinal Results
15th May 20148:23 amRNSResult of General Meeting
29th Apr 201411:59 amRNSProposed Restructuring of the Group
13th Dec 20138:55 amRNSTrading Statement
20th Sep 20137:00 amRNSHalf Yearly Report
22nd Jul 20137:00 amRNSTrading Statement
8th Jul 201310:02 amRNSResult of AGM
12th Jun 20139:04 amRNSNotice of AGM and Posting of Annual Report
20th May 20137:00 amRNSFinal Results
29th Apr 20139:30 amRNSDirectorate Change
15th Feb 201310:56 amRNSDirectorate Change
25th Jan 20137:00 amRNSTrading Update
21st Jan 201310:18 amRNSDirectorate Change
1st Oct 20127:00 amRNSDirectorate Change
7th Sep 201210:51 amRNSHalf Yearly Report
31st Jul 20128:36 amRNSTrading Statement
17th Jul 20127:13 amRNSDividend Payment
17th Jul 20127:10 amRNSBuyout of key refinery subsidiary
19th Jun 20127:00 amRNSResult of AGM and Trading Update
29th May 20122:18 pmRNSDirector/PDMR Shareholding
28th May 201212:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.